TEMPEST THERAPEUTICS INC. - COMMON STOCK
0,9055
22-ноября-24 16:44:58
15 мин. задержка
Акции
+0,0119
+1,33%
Сегодняшний диапазон
0,8660 - 0,9282
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Tempest Presents Promising Preclinical Data on Two Oncology Programs at the 2022 AACR Annual Meeting
08 апр 2022 13:00:00 Источник Nasdaq GlobeNewswire
-
Tempest Reports Year End 2021 Financial Results and Provides Business Update
29 мар 2022 16:00:00 Источник Nasdaq GlobeNewswire
-
Tempest to Present at the 32nd Annual Oppenheimer Healthcare Conference
10 мар 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
08 мар 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
Tempest to Present at the 11th Annual SVB Leerink Healthcare Conference
09 фев 2022 08:00:03 Источник Nasdaq GlobeNewswire
-
Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
18 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
12 ноя 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
10 ноя 2021 16:05:01 Источник Nasdaq GlobeNewswire
-
Tempest to Present at Two Upcoming Investor Conferences in November
09 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
Tempest Further Bolsters Patent Portfolio with Issuance of Multiple Patents for TPST-1495
08 ноя 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Tempest Announces Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
01 окт 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
20 сен 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
13 сен 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Tempest to Present at Upcoming Investor Conferences
09 сен 2021 16:01:00 Источник Nasdaq GlobeNewswire